{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:34:15Z","timestamp":1795026855671,"version":"4.10.2"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aims:<\/jats:title>\n            <jats:p>Early identification of malignant biliary strictures (MBSs) is challenging, with up to 20% classified as indeterminants after preliminary testing and tissue sampling with endoscopic retrograde cholangiopancreatography. We aimed to evaluate the use of methylated DNA markers (MDMs) from biliary brushings to enhance MBS detection in a prospective cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach:<\/jats:title>\n            <jats:p>Candidate MDMs were evaluated for their utility in MBS diagnosis through a series of discovery and validation phases. DNA was extracted from biliary brushing samples, quantified, bisulfite-converted, and then subjected to methylation-specific droplet digital polymerase chain reaction. \u202fPatients were considered to have no malignancy if the sampling was negative and there was no evidence of malignancy after 1 year or definitive negative surgical histopathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fourteen candidate MDMs were evaluated in the discovery phase, with top-performing and new markers evaluated in the technical validation phase. The top 4 MDMs were TWIST1, HOXA1, VSTM2B, and CLEC11A, which individually achieved AUC values of 0.82, 0.81, 0.83, and 0.78, respectively, with sensitivities of 59.4%, 53.1%, 62.5%, and 50.0%, respectively, at high specificities for malignancy of 95.2%\u201395.3% for the final biologic validation phase. When combined as a panel, the AUC was 0.86, achieving 73.4% sensitivity and 92.9% specificity, which outperformed cytology and fluorescence in situ hybridization (FISH).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The selected MDMs demonstrated improved performance characteristics for the detection of MBS compared to cytology and FISH. Therefore, MDMs should be considered viable candidates for inclusion in diagnostic testing algorithms.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hep.0000000000000970","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T19:00:58Z","timestamp":1718996458000},"page":"453-464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Utility of methylated DNA markers for the diagnosis of malignant biliary strictures"],"prefix":"10.1097","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1855-7651","authenticated-orcid":false,"given":"Matthew A.","family":"Cooley","sequence":"first","affiliation":[{"name":"Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber R.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-563X","authenticated-orcid":false,"given":"Emily G.","family":"Barr Fritcher","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-2512","authenticated-orcid":false,"given":"Dragana","family":"Milosevic","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Levy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-3954","authenticated-orcid":false,"given":"Amber R.","family":"Bridgeman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret T.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-7225","authenticated-orcid":false,"given":"Barham K.","family":"Abu Dayyeh","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-5235","authenticated-orcid":false,"given":"Andrew C.","family":"Storm","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Law","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8886-0376","authenticated-orcid":false,"given":"Eric J.","family":"Vargas","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Garimella","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Zemla","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Research Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Research Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Research Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-009X","authenticated-orcid":false,"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-8574","authenticated-orcid":false,"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-0118","authenticated-orcid":false,"given":"Benjamin R.","family":"Kipp","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6209-9905","authenticated-orcid":false,"given":"Vinay","family":"Chandrasekhara","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"R1-20250116","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2012.173","article-title":"Biliary tract cancers in Olmsted County, Minnesota, 1976-2008","volume":"107","author":"Yang","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R2-20250116","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/hep4.1730","article-title":"DNA methylation markers for detection of cholangiocarcinoma: Discovery, validation, and clinical testing in biliary brushings and plasma","volume":"5","author":"Yang","year":"2021","journal-title":"Hepatol Commun"},{"key":"R3-20250116","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/hep.32007","article-title":"Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States","volume":"74","author":"Lee","year":"2021","journal-title":"Hepatology"},{"key":"R4-20250116","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20250116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21037\/cco.2016.10.09","article-title":"Biliary tract cancers: Epidemiology, molecular pathogenesis and genetic risk associations","volume":"5","author":"Marcano-Bonilla","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"R6-20250116","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/cncr.34436","article-title":"Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States","volume":"128","author":"Lee","year":"2022","journal-title":"Cancer"},{"key":"R7-20250116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gtc.2015.10.009","article-title":"The role of endoscopic retrograde cholangiopancreatography in management of pancreatic diseases","volume":"45","author":"Riff","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"R8-20250116","doi-asserted-by":"crossref","first-page":"E1233","DOI":"10.1055\/a-1897-4686","article-title":"Histological assessment of new cholangioscopy-guided forceps in ERCP biliary stricture sampling: A blinded comparative study","volume":"10","author":"Vargas","year":"2022","journal-title":"Endosc Int Open"},{"key":"R9-20250116","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gie.2022.08.021","article-title":"Identification of patients with malignant biliary strictures using a cholangioscopy-based deep learning artificial intelligence (with video)","volume":"97","author":"Marya","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"R10-20250116","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.gie.2021.11.029","article-title":"Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis","volume":"95","author":"Baroud","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"R11-20250116","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An optimized set of fluorescence in situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples","volume":"149","author":"Barr Fritcher","year":"2015","journal-title":"Gastroenterology"},{"key":"R12-20250116","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"key":"R13-20250116","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0038-1655775","article-title":"Emerging technologies for the diagnosis of perihilar cholangiocarcinoma","volume":"38","author":"Rizvi","year":"2018","journal-title":"Semin Liver Dis"},{"key":"R14-20250116","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s10620-019-05866-2","article-title":"Cholangioscopy biopsies improve detection of cholangiocarcinoma when combined with cytology and FISH, but not in patients with PSC","volume":"65","author":"Kaura","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R15-20250116","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R16-20250116","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R17-20250116","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann Oncol"},{"key":"R18-20250116","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cgh.2021.08.010","article-title":"Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma","volume":"20","author":"Chalasani","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R19-20250116","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.gie.2021.07.005","article-title":"Diagnostic power of DNA methylation markers suggestive of cholangiocarcinoma in ERCP-based brush cytology","volume":"95","author":"Prachayakul","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"R20-20250116","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/cncr.26558","article-title":"Stool DNA testing for the detection of pancreatic cancer: Assessment of methylation marker candidates","volume":"118","author":"Kisiel","year":"2012","journal-title":"Cancer"},{"key":"R21-20250116","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.30244","article-title":"Hepatocellular carcinoma detection by plasma methylated DNA: Discovery, phase I pilot, and phase II clinical validation","volume":"69","author":"Kisiel","year":"2019","journal-title":"Hepatology"},{"key":"R22-20250116","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1158\/1078-0432.CCR-14-2469","article-title":"New DNA methylation markers for pancreatic cancer: Discovery, tissue validation, and pilot testing in pancreatic juice","volume":"21","author":"Kisiel","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R23-20250116","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jmoldx.2012.01.014","article-title":"Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity","volume":"14","author":"Shin","year":"2012","journal-title":"J Mol Diagn"},{"key":"R24-20250116","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5858\/2007-131-923-MPOMCI","article-title":"Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas","volume":"131","author":"Kim","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R25-20250116","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.3800287","article-title":"Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma","volume":"18","author":"Yang","year":"2005","journal-title":"Mod Pathol"},{"key":"R26-20250116","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.26721","article-title":"Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway","volume":"59","author":"Goeppert","year":"2014","journal-title":"Hepatology"},{"key":"R27-20250116","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3748\/wjg.v11.i9.1333","article-title":"Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma","volume":"11","author":"Chen","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R28-20250116","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.3748\/wjg.v17.i29.3407","article-title":"Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma","volume":"17","author":"Shu","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R29-20250116","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R30-20250116","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3923\/pjbs.2013.1823.1825","article-title":"Standardization of DNA extraction from methanol acetic acid fixed cytogenetic cells of cattle and buffalo","volume":"16","author":"Kotikalapudi","year":"2013","journal-title":"Pak J Biol Sci"},{"key":"R31-20250116","first-page":"500","article-title":"DNA extraction from fixed cytogenetic cell suspensions","volume":"6","author":"Amorim","year":"2007","journal-title":"Genet Mol Res"},{"key":"R33-20250116","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R34-20250116","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.humpath.2008.02.003","article-title":"A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett\u2019s esophagus","volume":"39","author":"Barr Fritcher","year":"2008","journal-title":"Hum Pathol"},{"key":"R35-20250116","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1053\/j.gastro.2009.02.040","article-title":"A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures","volume":"136","author":"Barr Fritcher","year":"2009","journal-title":"Gastroenterology"},{"key":"R36-20250116","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/1533034617748090","article-title":"DNA methylation markers improve the sensitivity of endoscopic retrograde cholangiopancreatography-based brushing cytology in extrahepatic cholangiocarcinoma","volume":"16","author":"Prachayakul","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"R37-20250116","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.gie.2016.11.012","article-title":"Multitarget stool DNA test: Clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening","volume":"85","author":"Johnson","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"R38-20250116","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10620-014-3451-5","article-title":"Multi-target stool DNA test: A new high bar for noninvasive screening","volume":"60","author":"Ahlquist","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R39-20250116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.gastro.2011.10.031","article-title":"Next-generation stool DNA test accurately detects colorectal cancer and large adenomas","volume":"142","author":"Ahlquist","year":"2012","journal-title":"Gastroenterology"},{"key":"R40-20250116","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/1078-0432.CCR-20-0235","article-title":"High detection rates of pancreatic cancer across stages by plasma assay of novel methylated DNA markers and CA19-9","volume":"27","author":"Majumder","year":"2021","journal-title":"Clin Cancer Res"},{"key":"R41-20250116","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","article-title":"DNA methylation in cancer and aging","volume":"76","author":"Klutstein","year":"2016","journal-title":"Cancer Res"},{"key":"R42-20250116","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HEP.0000000000000970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T14:02:18Z","timestamp":1737036138000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HEP.0000000000000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/hep.0000000000000970","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"2023-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}